In vitro activity of gemifloxacin and contemporary oral antimicrobial agents against 27,247 Gram-positive and Gram-negative aerobic isolates: a global surveillance study

This publication has 30 references indexed in Scilit:

• Clinical resistance encountered in the respiratory surveillance program (RESP) study: a review of the implications for the treatment of community-acquired respiratory tract infections
  The American Journal of Medicine, 2001
• Future of the quinolones☆
  Seminars in Respiratory Infections, 2001
• Controlling Antimicrobial Resistance in Hospitals: Infection Control and Use of Antibiotics
  Emerging Infectious Diseases, 2001
• In Vitro Development of Resistance to Six Quinolones in Streptococcus pneumoniae, Streptococcus pyogenes , and Staphylococcus aureus
  Antimicrobial Agents and Chemotherapy, 2001
• Analysis of Ciprofloxacin Activity against Streptococcus pneumoniae after 10 Years of Use in the United States
  Antimicrobial Agents and Chemotherapy, 2000
• Antimicrobial Resistance in Respiratory Tract Pathogens: Results of an International Surveillance Study
  Chemotherapy, 2000
• Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997–1998
  Journal of Antimicrobial Chemotherapy, 1999
• Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe
  Infection, 1999
• The New Fluoroquinolones: A Critical Review
  Canadian Journal of Infectious Diseases and Medical Microbiology, 1999
• Antimicrobial susceotibilirv of bacterial isolates in South Sweden including a 13‐year follow‐up study of some respiratory tract pathogens
  APMIS, 1994